Integrated platform for producing a portfolio of egg-derived protein and peptide ingredients with tailored molecular weight, solubility, viscosity, thermal stability, and sensory properties, enabling application-specific functionality for food and nutrition products.
This technology is an integrated, scalable egg-protein modification platform that produces a portfolio of differentiated protein and peptide ingredients. Rather than a single generic hydrolysate, the platform generates ingredients with tailored molecular-weight distributions, solubility, viscosity, thermal stability, sensory characteristics, and application-specific functionality. This addresses the need for versatile functional ingredients in food, beverage, and nutrition applications.
The platform combines controlled enzymatic hydrolysis, membrane-based fractionation, selective peptide recovery, debittering, stabilization, and drying. Key features include:
The research systematically investigates relationships between enzyme specificity, degree of hydrolysis, peptide molecular-weight distribution, sequence characteristics, and functional performance to fine-tune the process.
The technology is currently at the research stage. A detailed hypothesis and methodology have been established, and future validation plans are in place to test the platform's ability to produce tailored hydrolysates. Systematic investigation of hydrolysis parameters and separation techniques is proposed to validate functional performance and scale-up potential.
Gadjah Mada University is a comprehensive public research university in Yogyakarta, Indonesia, with a large multidisciplinary student body and a national role in education and innovation. A research and technology park on campus offers pilot-scale facilities, prototyping workshops, and shared labs that co-locate companies with researchers. An integrated academic hospital enables clinical studies and translational partnerships, while industry internships and co-supervised capstones build workforce pipelines. Research activity is supported by competitive funding from Indonesian national ministries and research agencies, as well as international sponsors and development partners. A dedicated technology transfer office manages IP, licensing, and startup incubation for industry partners.